Single logo
LoginSign Up

GDP Transportation and Logistics Audit Checklist

A specialized checklist for auditing GDP compliance in pharmaceutical transportation and logistics, focusing on vehicle qualification, route planning, security measures, and third-party logistics management.

GDP Transportation and Logistics Audit Checklist

by: audit-now
4.4

Get Template

About This Checklist

Effective transportation and logistics management is crucial for maintaining Good Distribution Practice (GDP) compliance in the pharmaceutical industry. This comprehensive GDP Transportation and Logistics Audit Checklist is designed to help pharmaceutical companies evaluate and improve their distribution processes, focusing on the movement of products from manufacturers to end-users. By addressing key areas such as vehicle qualification, route planning, security measures, and third-party logistics providers, this checklist enables auditors to thoroughly assess compliance with GDP transportation requirements. Regular use of this checklist can significantly reduce risks associated with product damage, theft, and contamination during transit, ultimately ensuring the safe and efficient delivery of pharmaceutical products to patients.

Learn more

Industry

Healthcare

Standard

GDP - Good Distribution Practice

Workspaces

and Transportation Vehicles
Distribution Centers
Logistics Centers

Occupations

Logistics Manager
Supply Chain Specialist
Transportation Coordinator
Quality Assurance Auditor
Freight Forwarder
1
Is the transportation process compliant with Good Distribution Practices (GDP)?
2
Describe the procedures for maintaining temperature control during transportation.
3
What is the acceptable temperature range for the vehicle during transport?
Min: 2
Target: 2-8
Max: 8
4
Is the third-party logistics provider evaluated for their suitability?
5
Is the route planning process optimized for efficiency?
6
Is the inventory control system in place and functioning effectively?
7
What is the frequency of inventory audits conducted?
8
What is the maximum allowable discrepancy percentage for inventory counts?
Min: 0
Target: 1
Max: 5
9
Is there a mechanism in place for product traceability throughout the supply chain?
10
Are emergency procedures documented and available for inventory management?
11
Are security protocols implemented for the transportation of pharmaceuticals?
12
How often is security training provided to staff involved in pharmaceutical transportation?
13
How many security incidents were reported in the past year during transportation?
Min: 0
Target: 0
Max: 100
14
Are access control measures in place for transportation vehicles?
15
Are surveillance systems installed in transportation vehicles?
16
Is the packaging compliant with regulatory standards for pharmaceutical transport?
17
Describe how labeling requirements are adhered to during transportation.
18
How many packaging failures were reported in the past year?
Min: 0
Target: 0
Max: 50
19
Are tamper-evident features included in the product packaging?
20
Is recycling information included on the packaging?
21
Are suppliers qualified based on regulatory requirements?
22
What is the frequency of performance reviews for suppliers?
23
How many non-conformances were reported for suppliers in the past year?
Min: 0
Target: 0
Max: 100
24
Is a risk assessment conducted for each supplier?
25
Are communication protocols established with suppliers?

FAQs

The audit should cover various types of vehicles used in pharmaceutical distribution, including temperature-controlled trucks, vans, air freight containers, and sea freight containers.

Vehicle qualification should be assessed by reviewing documentation of temperature mapping studies, maintenance records, cleaning procedures, and compliance with GDP-specific requirements for pharmaceutical transport.

Security measures to evaluate include vehicle tracking systems, tamper-evident seals, locked compartments, driver background checks, and protocols for handling high-value or controlled substances.

This checklist provides a framework for evaluating the GDP compliance of third-party logistics providers, including their quality management systems, staff training, and adherence to contractual agreements.

The audit should assess route risk assessments, contingency plans for delays or emergencies, temperature monitoring during transit, and strategies to minimize product exposure to adverse conditions.

Benefits of GDP Transportation and Logistics Audit Checklist

Ensures comprehensive evaluation of transportation and logistics processes in pharmaceutical distribution

Helps identify potential risks and vulnerabilities in the supply chain

Facilitates compliance with GDP transportation requirements

Improves security and integrity of pharmaceutical products during transit

Supports optimization of distribution routes and logistics operations